Try Ageless Reviews: Every Price Is an Intro Price

The one-sentence version

Try Ageless has one of the broadest longevity menus here and the least trustworthy set of numbers attached to it. Every advertised longevity price is a limited-time rate you reach only with a discount code, every product page then says that "the final amount is shown after clinical review", and on one product the fine print quotes a band nearly double the price in the buy box. It grades C, 7 points out of 14, almost entirely on price transparency — the medicine, the intake and the clinician review are all real. The grade is computed from its published terms alone.

One disambiguation first, because the names collide. Try Ageless is the company reviewed here. AgelessRx is a different, unrelated company we grade separately in our AgelessRx review; the two share no ownership, pricing or menu, and nothing on this page describes it.

What it is, and who it's for

Try Ageless is an online storefront, not a membership. Its "Live Longer" shelf carries an NAD+ injection, a high-strength NAD+ injection, an NAD+ troche, low-dose naltrexone, methylene blue and MIC+B12; a separate wellness shelf carries sermorelin as an injection, a troche and a nasal spray; and a testosterone line and compounded GLP-1s sit beside them. Products are sold as one-month supplies, so nothing requires a prepay term — a genuine advantage over the prepay-only shops here. A licensed clinician reviews every questionnaire before anything ships, and the operating entity is named — on Try Ageless's own regulatory page — as Lovely Meds, Inc., of 131 Continental Dr, Suite 305, Newark, DE. That name matters more than it looks; see the regulatory record below.

The buyer this suits wants to try one compounded molecule for one month without joining anything. The buyer it does not suit needs to know the price before checkout. See what longevity care costs.

What it actually costs

The NAD+ injection (1,000 mg vial, one month's supply) shows $199 beside a struck-through $249, under a "Limited Time Offer" banner and an "INTRO SAVINGS" badge carrying the code WELCOME50 for "$50 off." $249 is the list price. $199 is a promotional rate.

Sermorelin injection (15 mg vial) shows $126 against a list of $176, code SERM50. Sermorelin nasal spray shows $149 against $199, code FIRST50. Low-dose naltrexone shows $99 against $149.

Then the sentence under every buy box: "Exact pricing depends on your prescribed dose. Final amount is shown after clinical review." Read plainly, no figure printed anywhere on the site is the figure you will be charged. It is a candid disclosure and a total defeat for price transparency — the rubric asks whether a buyer can know the cost before handing over a card, and here the site itself says no.

And on the sermorelin injection, the page disagrees with itself. The buy box says $126, discounted from $176. Scroll to the "Medical Information" block on the same page and the entry reads "Available Dosage Strengths — 15 mg — $239-$289." Same product, same page, two bands that do not overlap. The NAD+ injection's equivalent block reads $199–$249 and matches its buy box, so this is not a formatting quirk; one of the two sermorelin numbers is wrong, and a buyer cannot tell which.

Clinical oversight and the pharmacy

Oversight is stated and included: "licensed U.S. clinician reviews every case before any prescription is issued", with unlimited provider messaging and no lab work at any point. No lab gate is a convenience, not a virtue — nothing here measures whether anything worked. See longevity biomarker panels.

Pharmacy disclosure is better than the marketing suggests and worse than the badges imply. On its safety-information page, Try Ageless names both sides of the chain: the medical provider as Wasef Health, PC in Pinellas Park, Florida, and the dispensing pharmacy as Pharmacy Hub, 15600 NW 15th Ave, Miami, with a phone number. Very few providers here publish that at all. What it never does is classify that pharmacy: the only appearance of "503A" is inside a list of rules the company "is designed to support compliance with" — a scope statement about regulations, not a claim about who fills your prescription.

Against that, the product pages carry a trust strip reading "GMP Certified — FDA-registered facility" beside "Third-Party Tested" and "Sterility Tested 100%". That badge sits above medication the same page correctly calls "not FDA-approved… custom-prepared by licensed U.S. pharmacies." FDA's position is that compounded drugs are not FDA-approved, that it does not verify their safety, effectiveness or quality before marketing, and that 503A pharmacies specifically are not subject to current good manufacturing practice requirements¹. That badge is doing more work than the facts support.

The LegitScript badge is a third one to treat carefully. A seal sits in the footer carrying ID 123956, and it does not resolve, so the certification cannot be confirmed from it. That is unconfirmed, which is not the same as absent — the badge is there, and the identifier behind it does not lead anywhere. Ask, if it matters to you.

The regulatory record, and exactly what it is

FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds in September 2025 — reference MARCS-CMS 716829, issued 9 September 2025 and posted 16 September 2025 by the Center for Drug Evaluation and Research. It is not closed out. FDA's own index lists no close-out for it, so anyone describing this as a resolved matter is publishing a false impression. We are not going to summarize or relitigate what the letter says; that is FDA's document to characterize, and the searchable index is cited below² so you can read it in full yourself.

Why this appears on a Try Ageless page at all, since the letter never mentions Try Ageless. The letter is addressed to Lovely Meds and concerns Lovely Meds' own website. The connection is Try Ageless's own admission: its Medical Oversight & Regulatory Information page states, in its own words, "Try Ageless is a brand operated by Lovely Meds, Inc." We disclose on the strength of the company's own statement about who it is — not on an inference we drew.

Two things this letter is not. It is not a reason to drop Try Ageless from our rankings: a letter discloses, it does not disqualify, Try Ageless stays on the board, and the grade below is computed from published terms alone. And it is not the other record you may find by searching: FDA's index also returns Ageless Global, LLC (1 March 2021, concerning COVID-19 products). That is a different company with a similar name, and attributing it here would be wrong.

If you look it up yourself: FDA's index lists the letter under the spaced firm name "lovely meds", a form the storefront itself never uses, so a search for the brand name alone comes back clean. That is the search failing, not the record.

The evidence behind what it sells

Try Ageless's copy is more hedged than most — "may support", "individual responses vary" — and still promises more than the human research has shown. The NAD+ page says that "patients may experience improvements in energy, mental clarity, recovery, and overall wellness" and lists "Longevity Pathway Support." Raising your NAD+ level and feeling or functioning better are two different results, and injected NAD+ has not been shown to deliver the second. What the research does and does not show is in NAD+ for longevity and do NAD+ peptides actually work.

Sermorelin is sold here for "recovery, energy, body composition". It raises your own growth hormone, but that has not been shown to change muscle or fat in healthy older adults. The details are in sermorelin for longevity and what's proven versus hyped.

Where it's weak, and who should skip it

Skip it if you need a fixed price, and skip it if the $126-versus-$239 contradiction on the sermorelin page bothers you — it should. Treat the social proof carefully too: the rating strip on these longevity pages reads "4.8 based on 5 reviews", the first testimonial under a sermorelin listing is about starting GLP-1s, and the same weight-loss body copy and BMI calculator appear on the NAD+ page — which tells you which business these pages were built for.

If you proceed: get the clinical review, get the quoted final amount in writing, then decide. The intake is free, so nothing is lost by making them name the price first.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). Try Ageless takes the full four for its longevity line — NAD+ in three formats, sermorelin in three, plus LDN and methylene blue is one of the broadest shelves we grade — and two for a clinician review inside the price. It takes zero on price transparency, because every advertised longevity figure is an intro-code rate and the site states outright that the real number arrives after review. One of two on pharmacy — it publishes the name, and an address and a phone number with it, but claims no compounding standard for the facility. And zero for human support. Seven of fourteen. A C.

This is the most fixable C here. Print one honest price per product and make the fine print agree with the buy box, and Try Ageless would be graded on its menu instead of its marketing. Other C-graded providers are covered in the MadeMed review, the Shed review and the Wellorithm review; the full field is at our provider rankings and the scoring is in how we grade.